Asamedic AS

About Asamedic AS

Asamedic is a Norwegian pharma company established in 2013 to develop a liquid variant of ASA. Coxor has been approved in a European DCP and was launched with success in Norway in 2023. The product received great endorsement from KOLs, authorities, media and the public. Regulatory work for other continents is ongoing. Asamedic is seeking licensing partners for European countries, as well as for other geographic regions. For more information, see contact section below. You can read more about Asamedic at www.asamedic.no.

Read more Show less
Certifications
  • Other
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • NO
  • 2024
    On CPHI since
  • 1
    Certificates
  • 1 - 24
    Employees
Company types
OTC
Primary activities
OTC
View company profile
Contact info
  • +4790546049
  • Website
  • Rosenholm Campus, Rosenholmveien 25, Postboks 474 Bedriftssenteret,, 1411, Kolbotn, Akershus, Norway
Show contact info Hide contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024
View Exhibitor Profile

Products from Asamedic AS (1)

  • Coxor

    Product Coxor

    Coxor is a new drug formulation for treatment of acute heart attack. Heart attack is the no. 1 killer in the world, and no suited drug has been available for the public in spite of calls from scholars and KOLs on the subject. With Coxor, you have a liquid formulation with rapid onset-of action for the imme...